Drug and chemical firms relax patent controls for COVID-19 response

Thursday, May 14, 2020 - 20:10 in Mathematics & Economics

Gilead offers royalty-free licenses on remdesivir, consortium pledges not to prosecute IP violations done to fight the pandemic

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net